Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Extensive Stage Small Cell Lung Cancer × EC regimen × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Lung Neoplasms 1 Extensive Stage Small Cell Lung Cancer 1 Carcinoma, Neuroendocrine 1

Interventions

Etoposide 3 Carboplatin 3 atezolizumab 2 Cisplatin 2 tislelizumab 1 obinutuzumab 1 lutetium Lu 177 dotatate 1 durvalumab 1 ceralasertib 1 Paclitaxel 1 Injections 1 EC regimen 1 Drug Therapy 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05468489 2025-10-21

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Shanghai Henlius Biotech

Phase 3 Active not recruiting

Extensive Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡